使用四面体DNA纳米结构作为智能药物输送系统,彻底改变了癌症治疗
Ayushi Sharma1, Payal Vaswani2, Dhiraj Bhatia2
1Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University Mathura Uttar Pradesh-281406 India.
Nanoscale advances
|July 25, 2024
概括
四面体DNA纳米结构 (TDN) 对生物医学有很大的前景,特别是在药物输送和癌症治疗方面. 本综述探讨了TDN的修改和应用,强调了癌症治疗发展的未来方向.
科学领域:
- 生物医学是生物医学.
- 纳米技术纳米技术
- 分子生物学分子生物学
背景情况:
- DNA纳米结构在生物医学应用中具有显著的潜力.
- 四面体DNA纳米结构 (TDNs) 尤其以其稳定性,生物相容性和易于功能化而闻名.
- TDN是各种治疗和诊断药物的有前途的载体.
研究的目的:
- 审查TDNs的功能修改机制.
- 突出TDNs在癌症治疗中的应用.
- 讨论TDN在癌症治疗中的使用挑战和未来前景.
主要方法:
- 对TDN功能化研究的文献综述.
- 对TDN在药物输送,诊断和成像中的应用进行分析.
- 关于基于TDN的癌症治疗信息的综合.
主要成果:
- TDNs可以很容易地为各种应用程序进行合成和功能化.
- TDN 作为化学疗法,核酸疗法和成像探针的有效载体.
- 目前的研究广泛涵盖了TDN修饰和癌症治疗应用.
结论:
- TDNs为先进的生物医学应用提供了一个多功能平台,特别是在瘤学领域.
- 需要进一步的研究来应对现有的挑战,并充分实现TDNs的治疗潜力.
- 功能性修改策略是优化TDN用于向癌症治疗的关键.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


